Tikhonov D, Zhorov B
J Gen Physiol. 2023; 155(11).
PMID: 37728574
PMC: 10510735.
DOI: 10.1085/jgp.202313418.
Tandon R, Tandon N, Patil S
RSC Adv. 2022; 11(47):29333-29353.
PMID: 35479579
PMC: 9040805.
DOI: 10.1039/d1ra03874e.
Tikhonov D, Zhorov B
Membranes (Basel). 2022; 12(2).
PMID: 35207150
PMC: 8876033.
DOI: 10.3390/membranes12020229.
Kowalska M, Nowaczyk J, Nowaczyk A
Int J Mol Sci. 2020; 21(21).
PMID: 33143033
PMC: 7663169.
DOI: 10.3390/ijms21218099.
Wang Y, Tang S, Harvey K, Salyer A, Li T, Rantz E
Mol Pharmacol. 2018; 94(3):973-983.
PMID: 29980657
PMC: 11033928.
DOI: 10.1124/mol.118.112441.
Green approach for synthesis of bioactive Hantzsch 1,4-dihydropyridine derivatives based on thiophene moiety via multicomponent reaction.
Sharma M, Rajani D, Patel H
R Soc Open Sci. 2017; 4(6):170006.
PMID: 28680664
PMC: 5493906.
DOI: 10.1098/rsos.170006.
The ClusPro web server for protein-protein docking.
Kozakov D, Hall D, Xia B, Porter K, Padhorny D, Yueh C
Nat Protoc. 2017; 12(2):255-278.
PMID: 28079879
PMC: 5540229.
DOI: 10.1038/nprot.2016.169.
Functional, electrophysiological and molecular docking analysis of the modulation of Cav 1.2 channels in rat vascular myocytes by murrayafoline A.
Saponara S, Durante M, Spiga O, Mugnai P, Sgaragli G, Huong T
Br J Pharmacol. 2015; 173(2):292-304.
PMID: 26493241
PMC: 5341225.
DOI: 10.1111/bph.13369.
Extension of a protein docking algorithm to membranes and applications to amyloid precursor protein dimerization.
Viswanath S, Dominguez L, Foster L, Straub J, Elber R
Proteins. 2015; 83(12):2170-85.
PMID: 26404856
PMC: 4715591.
DOI: 10.1002/prot.24934.
Docking studies of phthalimide pharmacophore as a sodium channel blocker.
Iman M, Saadabadi A, Davood A
Iran J Basic Med Sci. 2013; 16(9):1016-21.
PMID: 24171082
PMC: 3804840.
Distinct properties of amlodipine and nicardipine block of the voltage-dependent Ca2+ channels Cav1.2 and Cav2.1 and the mutant channels Cav1.2/dihydropyridine insensitive and Cav2.1/dihydropyridine sensitive.
Lin M, Aladejebi O, Hockerman G
Eur J Pharmacol. 2011; 670(1):105-13.
PMID: 21910984
PMC: 3193569.
DOI: 10.1016/j.ejphar.2011.08.005.
Molecular determinants for activation of human ether-à-go-go-related gene 1 potassium channels by 3-nitro-n-(4-phenoxyphenyl) benzamide.
Garg V, Stary-Weinzinger A, Sachse F, Sanguinetti M
Mol Pharmacol. 2011; 80(4):630-7.
PMID: 21743002
PMC: 3187531.
DOI: 10.1124/mol.111.073809.
A homology model of the pore domain of a voltage-gated calcium channel is consistent with available SCAM data.
Bruhova I, Zhorov B
J Gen Physiol. 2010; 135(3):261-74.
PMID: 20176854
PMC: 2828909.
DOI: 10.1085/jgp.200910288.
Molecular modeling study of isoindolines as L-type Ca(2+) channel blockers by docking calculations.
Mancilla-Percino T, Correa-Basurto J, Trujillo-Ferrara J, Ramos-Morales F, Acosta Hernandez M, Cruz-Sanchez J
J Mol Model. 2010; 16(8):1377-82.
PMID: 20151167
DOI: 10.1007/s00894-010-0643-6.
Structural model for dihydropyridine binding to L-type calcium channels.
Tikhonov D, Zhorov B
J Biol Chem. 2009; 284(28):19006-17.
PMID: 19416978
PMC: 2707233.
DOI: 10.1074/jbc.M109.011296.
Outcome of a workshop on applications of protein models in biomedical research.
Schwede T, Sali A, Honig B, Levitt M, Berman H, Jones D
Structure. 2009; 17(2):151-9.
PMID: 19217386
PMC: 2739730.
DOI: 10.1016/j.str.2008.12.014.
A pore-blocking hydrophobic motif at the cytoplasmic aperture of the closed-state Nav1.7 channel is disrupted by the erythromelalgia-associated F1449V mutation.
Lampert A, OReilly A, Dib-Hajj S, Tyrrell L, Wallace B, Waxman S
J Biol Chem. 2008; 283(35):24118-27.
PMID: 18550534
PMC: 3259749.
DOI: 10.1074/jbc.M802900200.